Congratulations to the following faculty members for receiving these sponsored research awards:
Sponsored Research
Robert McGarrah III of Cardiology has received a sub-award (1OT2HL156812-01) through the DCRI-Duke-Site for a project entitled "RECOVER-ENERGIZE." Total funding will be $0.
Sanghee Hong of Cell Therapy has received an award from the American Society of Hematology for a project entitled "Barriers and Pathways: A Comprehensive Study on Return-to-Work for Hematopoietic Cell Transplantation Survivors." Total funding will be $150,000.
Mitchell Horwitz of Cell Therapy has received a sub-award (7R01-HL151365-05) through the The University of Kansas Medical Center Research Institute, Inc for a project entitled "Prebiotics to Optimize the Microbiota and Improve Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation." Total funding will be $114,875.
Jatin Roper of Gastroenterology has received a sub-award (1R01-CA289440-01A1) through the Yale University for a project entitled "Role and regulation of asparagine in colorectal cancer." Total funding will be $228,694.
Michael Pignone of General Internal Medicine has received an award from the University of Texas at Austin for a project entitled "CONNECT: developing a colorectal cancer screening plan for Texas." Total funding will be $11,500.
Maria Marquine of Geriatrics has received a sub-award (3U24-AG072122-03S1) through the University of Washington for a project entitled "Adaptation to Spanish of the Uniform Data System Version 4." Total funding will be $164,294.
Scott Antonia of Oncology has received an award (2P30-CA014236-51) from the National Institutes of Health for a project entitled "Immuno/Oncology (IO), a part of 's project entitled ""." Total funding will be $0.
Andrew Armstrong of Oncology has received an award (2P30-CA014236-51) from the National Institutes of Health for a project entitled "Protocol Review & Monitoring Committee, a part of 's project entitled ""." Total funding will be $0.
Gerard Blobe of Oncology has received an award (2P30-CA014236-51) from the National Institutes of Health for a project entitled "Cancer Research Training and Education Coordination (CRTEC), a part of 's project entitled ""." Total funding will be $0.
April Salama of Oncology has received a sub-award () through the University of Florida for a project entitled "UF-CUT-002 - A Phase 1/2 Study of Oral IRAK-4 inhibitor CA-4948 in combination with Pembrolizumab following stereotactic radiosurgery in patients with melanoma brain metastases." Total funding will be $8,500.
Thomas Stinchcombe of Oncology has received an award (2P30-CA014236-51) from the National Institutes of Health for a project entitled "Clinical Protocol & Data Management (CPDM), a part of 's project entitled ""." Total funding will be $0.
John Strickler of Oncology has received an award (2P30-CA014236-51) from the National Institutes of Health for a project entitled "Precision Cancer Med (PCM) & Investigation, a part of 's project entitled ""." Total funding will be $0.
Christopher Cox of Pulmonary has received an award (4UH3-HL168487-01) from the National Institutes of Health for a project entitled "1/2 Self-directed mobile adaptive coping skills intervention to improve psychological distress symptoms among cardiorespiratory failure survivors: the Blueprint RCT." Total funding will be $2,952,348.
Isaretta Riley of Pulmonary has received a sub-award () through the Brigham and Women's Hospital for a project entitled "i-CARE- Improving the quality of Care for Asthma patients at Risk of Exacerbations." Total funding will be $77,000.
Industry Sponsored Clinical Trials
James Daubert of Cardiology has received an award from Rocket Pharmaceuticals, Ltd for a project entitled "The Natural History of Arrhythmogenic Cardiomyopathy with Pathogenic PKP2 Variants (PKP2-ACM): An observational cohort study." Total funding will be $201,026.
Marat Fudim of Cardiology has received an award from AstraZeneca AB for a project entitled "A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function." Total funding will be $232,815.
Christopher Granger of Cardiology has received an award from Alnylam Pharmaceuticals for a project entitled "KARDIA-6 CVOT SUA." Total funding will be $17,952,477.
William Jones of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "V-Intervention." Total funding will be $41,317,740.
Michel Khouri of Cardiology has received an award from Moleculin Biotech, Inc. for a project entitled "MB-108 (Core Lab)." Total funding will be $2,029,841.
Daniel Mark of Cardiology has received an award from Cytokinetics, Inc. for a project entitled "Comet-HF Health Economics." Total funding will be $1,407,475.
Andrew Wang of Cardiology has received an award from Lexicon Pharmaceuticals for a project entitled "SONATA-HCM A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic obstructive And non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)." Total funding will be $207,376.
Sanghee Hong of Cell Therapy has received a sub-award () through National Marrow Donor Program for a project entitled "A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Inten." Total funding will be $91,803.
Lindsay Rein of Cell Therapy has received an award from Merck Sharp & Dohme LLC. for a project entitled "A Multicenter, Open-Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Participants Enrolled in a Prior Bomedemstat Clinical Study." Total funding will be $2,596,714.
Thomas Ortel of Hematology has received an award from Octapharma AG for a project entitled "A multicentre, prospective, open-label, uncontrolled Phase 3 study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing surgery or delivery." Total funding will be $122,642.
Carey Anders of Oncology has received a sub-award () through Johns Hopkins University for a project entitled "Prospective Registry of Trastuzumab Deruxtecan in Patients with Active/Progressive HER2-Positive Breast Cancer Brain Metastases." Total funding will be $71,529.
Jeffrey Clarke of Oncology has received an award from MedPacto, Inc for a project entitled "First-in-Human Dose-Escalation Study of TEW-7197 Monotherapy in Subjects with Advanced Stage Solid Tumors." Total funding will be $49,482.
Vidhya Karivedu of Oncology has received an award from Merus N.V. for a project entitled "A phase 3 randomized, open-label study to evaluate the efficacy and safety of petosemtamab plus pembrolizumab vs pembrolizumab in first-line treatment of recurrent or metastatic PD-L1+ head and neck squamous cell carcinoma.." Total funding will be $460,105.
Vidhya Karivedu of Oncology has received an award from Merus N.V. for a project entitled "Phase 3 open-label, randomized, controlled study to evaluate the efficacy & safety of petosemtamab compared with investigators choice monotherapy treatment in previously treated patients with incurable metastatic/recurrent head and neck squamous cell." Total funding will be $354,625.
Jameel Muzaffar of Oncology has received an award from Bicara Therapeutics Inc. for a project entitled "A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination with Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma." Total funding will be $950,146.